NCT02617186 Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT Status ACTIVE_NOT_RECRUITING Phase NA
NCT02616393 Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases Status COMPLETED Phase PHASE2
NCT02613507 Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02604342 Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib Status COMPLETED Phase PHASE3
NCT02595450 A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase N/A
NCT02591615 Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC Status COMPLETED Phase PHASE2
NCT02590965 A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02587689 Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT02584699 Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC Status UNKNOWN Phase PHASE2
NCT02584634 Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101) Status TERMINATED Phase PHASE1/PHASE2
NCT02580708 Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02577627 Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC Status UNKNOWN Phase N/A
NCT02576665 A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) Status TERMINATED Phase PHASE1
NCT02575404 GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients Status COMPLETED Phase PHASE1
NCT02574078 A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT02573506 Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02572687 A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Status COMPLETED Phase PHASE1
NCT02570958 ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors Status WITHDRAWN Phase PHASE1
NCT02570815 Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer Status RECRUITING Phase PHASE1